Literature DB >> 12797860

Screening for ovarian cancer.

Cleola Anderiesz1, Michael A Quinn.   

Abstract

Ovarian cancer is the leading cause of death from gynaecological malignancies. No precancerous lesions have been identified. Bimanual examination has not been proven to be of value as a screening test. Transvaginal ultrasound examination, with or without measurement of CA 125 levels, is currently being evaluated for population screening. Women at high risk of ovarian cancer should be screened annually - with measurement of CA 125 level and transvaginal ultrasound examination.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12797860     DOI: 10.5694/j.1326-5377.2003.tb05399.x

Source DB:  PubMed          Journal:  Med J Aust        ISSN: 0025-729X            Impact factor:   7.738


  5 in total

1.  Ovarian carcinoma in two patients with chronic liver disease.

Authors:  Mehlika Isildak; Gulay-Sain Guven; Murat Kekilli; Yavuz Beyazit; Mustafa Erman
Journal:  World J Gastroenterol       Date:  2005-07-28       Impact factor: 5.742

Review 2.  Ovarian cancer in endometriosis: epidemiology, natural history, and clinical diagnosis.

Authors:  Hiroshi Kobayashi
Journal:  Int J Clin Oncol       Date:  2009-10-25       Impact factor: 3.402

Review 3.  Single Domain Antibodies as New Biomarker Detectors.

Authors:  Chiuan Herng Leow; Katja Fischer; Chiuan Yee Leow; Qin Cheng; Candy Chuah; James McCarthy
Journal:  Diagnostics (Basel)       Date:  2017-10-17

Review 4.  Screening, epidemiology, molecular biology, and treatment strategies for endometriosis-associated ovarian cancer.

Authors:  Hiroshi Kobayashi
Journal:  Reprod Med Biol       Date:  2009-09-26

5.  GyneScan: an improved online paradigm for screening of ovarian cancer via tissue characterization.

Authors:  U Rajendra Acharya; S Vinitha Sree; Sanjeev Kulshreshtha; Filippo Molinari; Joel En Wei Koh; Luca Saba; Jasjit S Suri
Journal:  Technol Cancer Res Treat       Date:  2013-12-06
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.